tirzepatide and stroke Does Shrink Your Heart? Evidence Safety Facts Tirzepatide Linked to Better CV

While gastrointestinal effects dominate the adverse event profile, patients and clinicians should remain vigilant for any unusual symptoms that may warrant further evaluation

Our team will ensure that it suits you by viewing your health record, goals, and development

Weight Loss Outcomes: 1.25 mg dose (20 weeks): 9.7% weight loss 5 mg dose (28 weeks): 16.2% weight loss 20 mg dose (36 weeks): 22.0% weight loss In contrast, placebo-treated participants showed minor weight gains of 1.9%, 2.3%, and 2.0% over the same periods

A systematic review of these data is available [17]

GLP-1 Medication Administered as a simple injection (usually once weekly) with ongoing dose adjustments as needed

(2026, February 3)